JP2023103205A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023103205A5 JP2023103205A5 JP2023060583A JP2023060583A JP2023103205A5 JP 2023103205 A5 JP2023103205 A5 JP 2023103205A5 JP 2023060583 A JP2023060583 A JP 2023060583A JP 2023060583 A JP2023060583 A JP 2023060583A JP 2023103205 A5 JP2023103205 A5 JP 2023103205A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- independently
- compound according
- butyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025116381A JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662353735P | 2016-06-23 | 2016-06-23 | |
| US62/353,735 | 2016-06-23 | ||
| JP2018567684A JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018567684A Division JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116381A Division JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023103205A JP2023103205A (ja) | 2023-07-26 |
| JP2023103205A5 true JP2023103205A5 (cg-RX-API-DMAC7.html) | 2023-10-18 |
Family
ID=60675799
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018567684A Active JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
| JP2023060583A Pending JP2023103205A (ja) | 2016-06-23 | 2023-04-04 | 腫瘍死滅に影響する二重標的構築物 |
| JP2025116381A Pending JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018567684A Active JP7317505B2 (ja) | 2016-06-23 | 2017-06-22 | 腫瘍死滅に影響する二重標的構築物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116381A Pending JP2025148450A (ja) | 2016-06-23 | 2025-07-10 | 腫瘍死滅に影響する二重標的構築物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10179117B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3474903B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7317505B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102864909B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN109843339B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017281364B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3028978A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL263863B (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201811482YA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017223357A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10806806B2 (en) | 2016-06-23 | 2020-10-20 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| SG11201811482YA (en) * | 2016-06-23 | 2019-01-30 | Univ Cornell | Double targeted constructs to affect tumor kill |
| MX392700B (es) | 2016-08-10 | 2025-03-11 | Cancer Targeted Tech Llc | Inhibidores de antígeno de la membrana específico para la próstata (psma) quelados. |
| CN109982998A (zh) * | 2016-11-23 | 2019-07-05 | 癌靶技术有限责任公司 | 白蛋白结合psma抑制剂 |
| JP7373998B2 (ja) | 2017-05-02 | 2023-11-06 | コーネル・ユニバーシティー | 有効性がより大きくかつ毒性がより少ない腫瘍標的指向方法及び試薬 |
| KR102403970B1 (ko) * | 2018-12-27 | 2022-05-31 | (주)퓨쳐켐 | 카르복시산이 도입된 psma-표적 화합물 및 그의 용도 |
| CN114685599A (zh) * | 2020-12-30 | 2022-07-01 | 南京江原安迪科正电子研究发展有限公司 | 一种psma靶向抑制剂及放射性核素标记的psma靶向抑制剂、制备方法和用途 |
| KR20230173150A (ko) | 2021-04-20 | 2023-12-26 | 테라파워, 엘엘씨 | Ac-225 생성용 티타니아 기반 발생기 |
| CN115448856B (zh) * | 2022-09-30 | 2023-09-22 | 北京师范大学 | 一种用于靶向PSMA的EuK二聚体化合物、衍生物及其应用 |
| WO2025213026A1 (en) * | 2024-04-04 | 2025-10-09 | Lantheus Medical Imaging, Inc. | Astatine-211-labelled psma-binding compounds |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
| US8921528B2 (en) | 2004-06-01 | 2014-12-30 | Domantis Limited | Bispecific fusion antibodies with enhanced serum half-life |
| WO2006091796A2 (en) | 2005-02-22 | 2006-08-31 | Acucela, Inc. | Compositions and methods for diagnosing and treating retinal diseases |
| GB0621973D0 (en) * | 2006-11-03 | 2006-12-13 | Philogen Spa | Binding molecules and uses thereof |
| ES2684322T3 (es) * | 2006-11-08 | 2018-10-02 | Molecular Insight Pharmaceuticals, Inc. | Heterodímeros de ácido glutámico |
| ES2634894T3 (es) * | 2008-08-01 | 2017-09-29 | The Johns Hopkins University | Agentes de unión a PSMA y usos de los mismos |
| WO2010032248A2 (en) | 2008-09-17 | 2010-03-25 | Yeda Research And Development Co. Ltd. | Multifunctional albumin conjugates |
| AU2009322167B2 (en) * | 2008-12-05 | 2014-11-20 | Molecular Insight Pharmaceuticals, Inc. | Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA |
| WO2010065899A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof |
| JP5843338B2 (ja) | 2011-08-05 | 2016-01-13 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | 放射標識された前立腺特異的膜抗原阻害剤 |
| DK2766364T3 (da) | 2011-08-17 | 2024-09-30 | Merck & Cie | Folatkonjugater af albumin-bindende enheder |
| US20140079636A1 (en) | 2012-04-16 | 2014-03-20 | Dinesh U. Chimmanamada | Targeted therapeutics |
| AU2014336638C1 (en) | 2013-10-18 | 2020-09-17 | Novartis Ag | Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| US10140408B2 (en) | 2015-09-04 | 2018-11-27 | Qualcomm Incorporated | Selectively encrypting content for distribution from a receiver device to a companion device |
| WO2017070482A2 (en) * | 2015-10-22 | 2017-04-27 | The Johns Hopkins University | Psma targeted radiohalogenated ureas for cancer radiotherapy |
| US10806806B2 (en) | 2016-06-23 | 2020-10-20 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| SG11201811482YA (en) * | 2016-06-23 | 2019-01-30 | Univ Cornell | Double targeted constructs to affect tumor kill |
| KR102724812B1 (ko) | 2017-04-05 | 2024-11-01 | 코넬 유니버시티 | 영상화 및 항종양 치료요법에 유용한 조정 가능한 약동학을 갖는 삼작용성 작제물 |
| US11400165B2 (en) | 2017-11-04 | 2022-08-02 | Advanced Proteome Therapeutics Inc. | Composition and method for modifying polypeptides |
| KR20210148157A (ko) | 2019-04-03 | 2021-12-07 | 타베다 세라퓨틱스, 인코포레이티드 | Hsp90-결합 접합체 및 이의 제형 |
| ES3075769T3 (en) | 2019-05-10 | 2026-08-07 | Janssen Biotech Inc | Macrocyclic chelators and methods of use thereof |
| US12151004B2 (en) | 2020-01-31 | 2024-11-26 | University Of Saskatchewan | Methods and compositions for targeting disease related cell surface receptors using radiolabeled and/or cytotoxin labelled antibodies |
| CA3070610A1 (en) | 2020-01-31 | 2021-07-31 | Humphrey FONGE | Methods and compositions for targeting disease related cell surface receptors using radiolabeled and/or cytotoxin labelled antibodies |
| US20220143228A1 (en) | 2020-10-22 | 2022-05-12 | Actinium Pharmaceuticals, Inc. | Her3 radioimmunotherapy for the treatment of solid cancers |
| TW202233244A (zh) | 2020-11-10 | 2022-09-01 | 美商健生生物科技公司 | 巨環化合物及其使用方法 |
| AU2022213825A1 (en) | 2021-01-27 | 2023-09-14 | Janssen Biotech, Inc. | Immunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their uses |
| GEAP202316335A (en) | 2021-02-01 | 2023-10-10 | Bayer Ag | Multimeric chelator compounds for use in targeted radiotherapy |
| MX2023014069A (es) | 2021-05-27 | 2024-03-15 | Janssen Biotech Inc | Composiciones y métodos para el tratamiento del cáncer de próstata. |
| WO2023026236A1 (en) | 2021-08-27 | 2023-03-02 | Janssen Biotech, Inc. | Anti-psma radioconjugates and uses thereof |
| WO2023026235A1 (en) | 2021-08-27 | 2023-03-02 | Janssen Biotech, Inc. | Anti-psma antibodies and uses thereof |
| EP4408839A4 (en) | 2021-09-29 | 2025-08-06 | Univ Melbourne | MACROCYCLE-CONTAINING COMPOUNDS AND THEIR RADIOLABELED COMPLEXES, USED AS LIGANDS IN TARGETED RADIOTHERAPY APPLICATIONS |
| WO2023084396A1 (en) | 2021-11-09 | 2023-05-19 | Janssen Biotech, Inc. | Macrocyclic compounds and methods of making the same |
| EP4429718A1 (en) | 2021-11-09 | 2024-09-18 | Janssen Biotech, Inc. | Macrocyclic compounds and diagnostic uses thereof |
-
2017
- 2017-06-22 SG SG11201811482YA patent/SG11201811482YA/en unknown
- 2017-06-22 CN CN201780046339.7A patent/CN109843339B/zh active Active
- 2017-06-22 CN CN202310698783.4A patent/CN117069621A/zh active Pending
- 2017-06-22 EP EP17816235.0A patent/EP3474903B1/en active Active
- 2017-06-22 KR KR1020237009535A patent/KR102864909B1/ko active Active
- 2017-06-22 AU AU2017281364A patent/AU2017281364B2/en active Active
- 2017-06-22 KR KR1020197001426A patent/KR102513698B1/ko active Active
- 2017-06-22 WO PCT/US2017/038832 patent/WO2017223357A1/en not_active Ceased
- 2017-06-22 EP EP25153047.3A patent/EP4520745A3/en active Pending
- 2017-06-22 US US15/630,808 patent/US10179117B2/en active Active
- 2017-06-22 CA CA3028978A patent/CA3028978A1/en active Pending
- 2017-06-22 JP JP2018567684A patent/JP7317505B2/ja active Active
-
2018
- 2018-12-20 IL IL263863A patent/IL263863B/en unknown
-
2019
- 2019-01-11 US US16/246,422 patent/US10716772B2/en active Active
-
2020
- 2020-06-19 US US16/906,956 patent/US12186288B2/en active Active
-
2023
- 2023-04-04 JP JP2023060583A patent/JP2023103205A/ja active Pending
- 2023-06-08 AU AU2023203581A patent/AU2023203581B2/en active Active
-
2025
- 2025-01-06 US US19/011,473 patent/US20260091008A1/en active Pending
- 2025-07-10 JP JP2025116381A patent/JP2025148450A/ja active Pending